Picard Medical, Inc.
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The compa… Read more
Picard Medical, Inc. (PMI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.818x
Based on the latest financial reports, Picard Medical, Inc. (PMI) has a cash flow conversion efficiency ratio of -0.818x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.51 Million) by net assets ($7.97 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Picard Medical, Inc. - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Picard Medical, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Picard Medical, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Picard Medical, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PENTIXAPHARM HOLDING N AG
XETRA:PTP
|
N/A |
|
Korchip
KQ:126730
|
0.029x |
|
Stellar Resources Limited
PINK:SLROF
|
-0.699x |
|
MAG Holdings Berhad
KLSE:0095
|
-0.178x |
|
Siam Pan Group PCL
BK:SPG
|
0.014x |
|
Scilex Holding Company
NASDAQ:SCLX
|
-0.046x |
|
Ganesh Benzoplast Limited
NSE:GANESHBE
|
0.017x |
|
Home Federal Bancorp Louisiana
NASDAQ:HFBL
|
0.056x |
Annual Cash Flow Conversion Efficiency for Picard Medical, Inc. (2022–2024)
The table below shows the annual cash flow conversion efficiency of Picard Medical, Inc. from 2022 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-23.74 Million | $-11.87 Million | 0.500x | -83.29% |
| 2023-12-31 | $-3.55 Million | $-10.63 Million | 2.994x | +417.42% |
| 2022-12-31 | $11.37 Million | $-10.72 Million | -0.943x | -- |